12:00 AM
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

Apexigen Inc., Gansu Duyiwei deal

Apexigen granted Gansu Duyiwei's Shanghai Duyiwei Biotechnology Co. Ltd. subsidiary an exclusive license to develop and commercialize APX004 in China....

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >